HUANG; Kuo-Kuei

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUANG; Kuo-Kuei.The latest application filed is for "pharmaceutical formulations for a liquid dosage form and a controlled release dosage form".

Company Profile

7.7.14

HUANG; Kuo-Kuei - Zhubei City TW
Huang; Kuo-Kuei - Zhubei TW
Huang; Kuo-Kuei - Zhudong Township TW
Huang; Kuo-Kuei - Hsinchu County N/A TW
Huang; Kuo-Kuei - Zhudong Township, Hsinchu County N/A TW
Huang; Kuo-Kuei - Jhudong Township TW
Huang, Kuo-Kuei - Hsinchu TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Formulations For A Liquid Dosage Form And A Controlled Release Dosage Form App 20220249395 - HUANG; Kuo-Kuei ; et al.	2022-08-11
Method for treating an autoimmune neurological disease and/or neurodegenerative disease and pharmaceutical formulations for a liquid dosage form and a controlled release dosage form Grant 11,400,054 - Huang , et al. August 2, 2	2022-08-02
Multi-particulate Pharmaceutical Composition, Immediate Release Pellets, Sustained Release Pellets, Enteric Release Pellets And Use Thereof App 20210290557 - HUANG; Yu-Feng ; et al.	2021-09-23
Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis App 20210015882 - HUANG; Kuo-Kuei ; et al.	2021-01-21
Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis Grant 10,821,148 - Huang , et al. November 3, 2	2020-11-03
Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same Grant 10,696,638 - Chen , et al. June 30, 2	2020-06-30
Method For Treating Or Alleviating Autoimmune-related Diseases App 20200121753 - HUANG; Kuo-Kuei ; et al.	2020-04-23
Composition For Improving The Solubility Of Poorly Soluble Substances, Use Thereof And Complex Formulation Containing Thereof App 20190209706 - HUANG; Wen-Chia ; et al.	2019-07-11
Compounds For Inhibiting Agc Kinase And Pharmaceutical Compositions Comprising The Same App 20190194137 - CHEN; Chih-Hung ; et al.	2019-06-27
Method For Treating An Autoimmune Neurological Disease And/or Neurodegenerative Disease And Pharmaceutical Formulations For A Liquid Dosage Form And A Controlled Release Dosage Form App 20190000776 - HUANG; Kuo-Kuei ; et al.	2019-01-03
Pharmaceutical Composition For Treating Or Alleviating An Autoimmune Disease And/or Complication Thereof And/or Nephritis And Method For Treating Or Alleviating An Autoimmune Disease And/or Complication Thereof And/or Nephritis App 20170258865 - HUANG; Kuo-Kuei ; et al.	2017-09-14
Pharmaceutical Composition For Treating Or Alleviating Autoimmune-related Diseases And Method For Treating Or Alleviating Autoimmune-related Diseases App 20170209519 - HUANG; Kuo-Kuei ; et al.	2017-07-27
Extracts of Cynanchum sp. and active ingredients contained therein in use of arthritis treatment Grant 9,549,958 - Sheu , et al. January 24, 2	2017-01-24
Extracts Of Cynanchum Sp. And Active Ingredients Contained Therein In Use Of Arthritis Treatment App 20140134280 - Sheu; Jennline ; et al.	2014-05-15
Pharmaceutical composition with immunomodulating function Grant 8,597,693 - Shih , et al. December 3, 2	2013-12-03
Pharmaceutical Composition With Immunomodulating Function App 20120003250 - Shih; Ying-Chu ; et al.	2012-01-05
Plant Derived Compounds And Compound Formulae Containing The Same For The Treatment Of Cervical Cancer App 20090137661 - Shih; Ming-Kuang ; et al.	2009-05-28
Human tissue urokinase type plasminogen activator formulation App 20030077682 - Hung, Paul Porwen ; et al.	2003-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.